论文部分内容阅读
目的:观察阿托伐他汀治疗原发性高脂血症的疗效。方法:随机从我院2013年3月~2014年3月期间收治的原发性高脂血症患者中选取62例作为本次研究对象,分为两组,给予研究组阿托伐他汀治疗,对照组采用辛伐他汀治疗,回顾性分析两组治疗疗效。结果:治疗后,研究组总有效93.55%,对照组总有效率为83.77%,组间比较差异存在统计学方面的意义(P<0.05);治疗后,两组不良反应比较无明显差异(P>0.05)。结论:给予高脂血症患者阿托伐他汀治疗的疗效较为显著,且无明显不良反应,值得在临床上推广应用。
Objective: To observe the efficacy of atorvastatin in the treatment of primary hyperlipidemia. Methods: Sixty-two patients with primary hyperlipidemia admitted to our hospital from March 2013 to March 2014 were randomly divided into two groups. Patients in study group were treated with atorvastatin, The control group was treated with simvastatin, and the curative effects of the two groups were retrospectively analyzed. Results: After treatment, the total effective rate was 93.55% in the study group and 83.77% in the control group, with statistical significance (P <0.05). There was no significant difference between the two groups after treatment (P > 0.05). Conclusion: The treatment of atorvastatin in patients with hyperlipidemia is more effective and has no obvious adverse reactions, which is worth popularizing in clinic.